Related Experiment Video
Updated: Dec 23, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
The clinical data from 19 critically ill patients with coronavirus disease 2019: a single-centered, retrospective,
Jinping Zhang1, Peng Liu2, Morong Wang1
1ICU, Liyuan Hospital affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430071 China.
Insights
This study analyzed 19 critically ill coronavirus disease 2019 (COVID-19) patients, finding ground-glass changes on CT scans and elevated inflammatory markers. Higher D-dimer levels were observed in non-survivors, indicating its prognostic value.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Radiology
Background:
- Coronavirus disease 2019 (COVID-19) presents a significant global health challenge.
- Understanding the clinical spectrum and diagnostic markers of severe COVID-19 is crucial for patient management.
Purpose of the Study:
- To analyze the clinical features of COVID-19 patients.
- To evaluate diagnostic and treatment strategies for severe COVID-19 cases.
Main Methods:
- Retrospective analysis of 19 COVID-19 patients admitted to the ICU.
- Review of clinical manifestations, auxiliary examinations, and laboratory indices.
Main Results:
- Median age of patients was 73 years; 42.1% mortality rate.
- Common symptoms included fever (68.4%) and dry cough (15.8%).
- All patients showed ground-glass changes on chest CT; elevated hs-CRP and SAA were noted. D-dimer levels were significantly higher in non-survivors.
Conclusions:
- Critically ill COVID-19 patients often present with specific radiological findings and laboratory abnormalities.
- Elevated D-dimer levels may serve as a key indicator of poor prognosis in severe COVID-19.
Background:
The objectives of this study were to analyze the clinical features of coronavirus disease 2019 (COVID-19) and evaluate the diagnosis and treatment.
Methods:
A retrospective analysis of the clinical manifestation and auxiliary examination of 19 patients with COVID-19 from the Liyuan Hospital intensive care unit (ICU) between January 16, 2020 and February 20, 2020 was undertaken.
Results:
There were 11 male and 8 female cases among the patients. The median (range) age was 73 (38-91) years. Of these patients, 8 (42.1%) had died and the median duration from ICU admission to death was 2 (interquartile range (IQR): 1-10.75) days. Seven of these 8 patients had underlying diseases. The auxiliary examination showed fever (68.4%), dry cough (15.8%), dyspnea (10.5%), and diarrhea (5.3%). All 19 cases showed ground-glass changes on chest computed tomography. Serum hypersensitive C-reactive protein (hs-CRP) and serum amylase A (SAA) were clearly increased in all of the cases. Among the 19 cases, there were 16 (84.2%) cases in which the total number of lymphocytes decreased, 12 cases (63%) had reduced liver function, and 11 cases (58%) had deviant results for fibrinogen (FIB) and D-dimer, in particular, the D-dimer level was significantly higher in the non-survivors compared with the survivors.
Conclusion:
There were more men than women among critically ill patients. All of the cases showed ground-glass changes on chest computed tomography and the vast majority of patients displayed fever and dry cough. The clinical laboratory indices change significantly, especially the D-dimer level among non-survivors.
More Related Videos
Related Concept Videos
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-III
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Coronary Syndrome III: Diagnostic Studies
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History

